Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

http://www.wikidata.org/entity/Q37309837

about

alpha-Synuclein and neuronal cell death Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.Alpha-synuclein mRNA expression in oligodendrocytes in MSA.TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia.Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation Autosomal dominant Parkinson's disease caused by SNCA duplications.α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences.A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.The neuropathology of genetic Parkinson's disease.Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis Models of α-synuclein aggregation in Parkinson's disease.Multiple system atrophy: genetic or epigenetic?Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.α-Synuclein and Parkinsonism: Updates and Future Perspectives.Multisystem Lewy body disease and the other parkinsonian disorders.Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease.The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson's Disease.Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.Pathomechanisms of TDP-43 in neurodegeneration.A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity.The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions

P2860

Q21202835-9574ED5F-B58C-4C2C-B5CD-F88873A7B90D Q33616462-DB18AB4B-078B-48C0-892B-0B039AAFB107 Q34335126-12D8C781-4F67-4AEA-B549-FFCDA9607DDD Q34548507-8AB2EFDD-E817-4B49-ABA8-40FA5403BDB2 Q34648581-A246B80E-BC46-4BBB-9671-F1443F4BAE21 Q35070572-5D8FE6A5-0007-4913-A6BB-5D131BBA9122 Q35274780-4AF526DC-2A9C-4616-AF6B-FDA8344477E1 Q35996880-E4109EBA-2CC5-4544-A33B-472E06A5B487 Q36424977-B2F9614E-2FFA-4348-AA11-E15831D4FAC8 Q36765217-A29A152F-5578-49A5-B7EE-C946E96C1164 Q36925651-D28524D2-CCE2-4D31-88AF-C374400B0B2F Q37246534-F353018B-E974-4D87-898D-E2650C5EF796 Q37438098-BC66378F-2C53-4201-873F-B2D7DDF47F50 Q37997386-2583A218-FFE9-47C1-B64A-4DACEA5B7371 Q38128462-81D30EF1-038B-4F20-9929-20BCB1BD2578 Q38286574-ACF3AFC2-9BEB-43A5-A17B-9BBDACC66AC0 Q38303573-4AE486B9-65D3-4409-AFFB-460D544A07AC Q38669105-AB96FEC6-8039-4635-85D0-990DA140A091 Q38742153-2A1A507D-E5C6-4D67-BB21-7B0208DF4E91 Q40260539-74076E37-A0CD-4AE4-AE2D-5CF0A3B5962D Q42043156-9828ED7B-C1EB-4934-BC3E-60A0505A7E70 Q42508604-FEBA1E14-7CA9-4BC7-ABC1-8A677D245337 Q46626375-065BD3C3-4DCF-4643-9ADD-87CDAACD3E48 Q47619453-8519CC25-FAA3-42C3-9270-E007BD548F9D Q48183448-D9C233F4-B96A-468B-94E2-680FF87F8BDE Q52730092-7025E5D7-2B1D-478F-897C-F745C5E90F4F Q54543700-C1663842-EFFC-4419-A777-2822E28252CE Q57169903-D5FF414D-9A70-4272-8484-B008F101DF9F

P2860

Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

http://www.wikidata.org/entity/Q37309837

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical, neuropathological an ...... familial Parkinson's disease.

@en

Clinical, neuropathological an ...... familial Parkinson's disease.

@nl

type

label

Clinical, neuropathological an ...... familial Parkinson's disease.

@en

Clinical, neuropathological an ...... familial Parkinson's disease.

@nl

prefLabel

Clinical, neuropathological an ...... familial Parkinson's disease.

@en

Clinical, neuropathological an ...... familial Parkinson's disease.

@nl

P1433

Q37309837-65388882-9AA5-4CDA-9A12-0E5C8415D5EA

P1476

Q37309837-ACD5D272-5E72-4335-8DAE-192E039A7983

P2093

Q37309837-488C3983-AA3E-4EC2-8F84-24DE2BC8A8EB

Q37309837-581B1AB6-D150-4DDC-8DB4-F4911934A2F3

Q37309837-AC632FE2-7257-467E-9459-38EDCA60DEE7

Q37309837-BF970DCC-CCCC-4245-9215-118ABE0D7887

Q37309837-C32F0D7A-7B1F-4AAD-9434-4C68B071BA45

Q37309837-DFBC1B2A-C0A0-4DDF-BB5F-FA626D098970

P2860

Q37309837-048BC55C-6338-4074-AE4D-FC132C7EE297

Q37309837-09FB1E8E-6C54-48C5-9F1A-85E946B330A8

Q37309837-2C7BAFE5-747A-4665-B576-73A1F8F75E11

Q37309837-31A131B3-9376-4AA4-85EC-14056932E600

Q37309837-358A6B7E-BB07-4306-BC29-B8944536B377

Q37309837-465484FE-4453-4311-A7B0-0B10F8427264

Q37309837-47044FBE-9130-4D8C-AE55-16BD42DCAE32

Q37309837-4CF67317-EEEF-45B9-9BD2-0EDAE6BA79BC

Q37309837-507155FB-74EC-4D1F-83E8-819FEB32B357

Q37309837-51E2AF5E-4379-4333-9C1C-DA434559D64B

P2888

Q37309837-39B5E0DC-C975-4B64-A374-66FF85CE4344

P304

Q37309837-FE86EB8D-5905-4A2B-8A64-3EACDF7F35A4

P31

Q37309837-5FB7E5DE-AB28-4E56-9C19-615B20AC4D89

P356

Q37309837-62011DA6-6C7D-4076-976B-0230FEA269FE

P433

Q37309837-3A8DF2C6-3F9D-4C41-A2C6-15013B494322

P478

Q37309837-DC5D2CE7-D3A7-4AAF-A8D6-9F0280F5BB41

P50

Q37309837-0FAF6D19-1635-45D8-931B-2EC92A226B6C

Q37309837-C7AC8B66-11C2-4130-9765-2927ED82A920

P577

Q37309837-3FED57B7-F653-4FA5-81DB-637B582CD190

P5875

Q37309837-C2C3FDAD-E8CD-44EC-94F8-1395AB3F377A

P698

Q37309837-6BAEC16D-9DAE-47E3-BAA5-DAD77409C376

P921

Q37309837-213B9BD3-BD27-44A2-A5D1-CA07ED6C9FF2

P932

Q37309837-125BC18E-F3A7-40B5-BD4E-4539431111B6

P356

S00401-008-0372-4

P1433

Acta Neuropathologica

P1476

Clinical, neuropathological an ...... familial Parkinson's disease.

@en

P2093

B A Chase

http://www.w3.org/2001/XMLSchema#string

K Markopoulou

http://www.w3.org/2001/XMLSchema#string

L Avery

http://www.w3.org/2001/XMLSchema#string

L Katechalidou

http://www.w3.org/2001/XMLSchema#string

M S Stansbury

http://www.w3.org/2001/XMLSchema#string

R D McComb

http://www.w3.org/2001/XMLSchema#string

P2860

Interface between tauopathies and synucleinopathies: A tale of two proteins

Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping

Higher order arrangement of the eukaryotic nuclear bodies.

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

P2888

s00401-008-0372-4

P304

25-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-008-0372-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

Zbigniew K Wszolek

P577

2008-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5463814

http://www.w3.org/2001/XMLSchema#string

P698

18389263

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2728685

http://www.w3.org/2001/XMLSchema#string